A Comparison of CAR-T and CAR-NK Cell Therapies

Our immune system plays a central role in fighting cancer. However, tumor cells can avoid detection and immune attack and progress to cancer. Immuno-oncological therapies have come of age in turning the tide, and we can now engineer T and NK cells with chimeric antigen receptors (CARs) to target specific tumors.


CAR-T Infographic


Learn more about our other Immuno-Oncology Research Tools >



Login / Register
Remember me
Forgot your password? Reset password?
Create an Account